Treatment Trials

1 Clinical Trials for Various Conditions

Focus your search

      COMPLETED
      Pilot of Abatacept-based Immunosuppression for Prevention of Acute GvHD During Unrelated Donor HCT
      Description

      The primary objective of the study is to determine the safety and tolerability when adding abatacept to acute Graft versus Host Disease in transplants for malignant diseases using unrelated donor bone marrow or peripheral blood stem cell grafts.

      Conditions
      AMLALLUndifferentiated LeukemiaBiphenotypic LeukemiaRefractory AnemiaRefractory Anemia With Ringed SideroblastsRefractory Cytopenia With Multilineage DysplasiaRef. Cytopenia w Multilineage Dysplasia & Ringed SideroblastsRefractory Anemia With Excess Blasts-1 (5-10% Blasts)Refractory Anemia With Excess Blasts-2 (10-20% Blasts)Myelodysplastic Syndrome, UnclassifiedMDS Associated With Isolated Del (5q)
      Talk to us